Nomura Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.7K | Sell |
260
-5,290
| -95% | -$1.28M | ﹤0.01% | 1044 |
|
|
2025
Q1 | $1.35M | Hold |
5,550
| – | – | ﹤0.01% | 740 |
|
|
2024
Q4 | $1.82M | Hold |
5,550
| – | – | 0.01% | 739 |
|
|
2024
Q3 | $1.86M | Sell |
5,550
-182
| -3% | -$60.9K | 0.01% | 740 |
|
|
2024
Q2 | $1.57M | Buy |
5,732
+99
| +2% | +$27K | 0.01% | 745 |
|
|
2024
Q1 | $1.95M | Sell |
5,633
-124
| -2% | -$42.9K | 0.01% | 725 |
|
|
2023
Q4 | $1.86M | Sell |
5,757
-717
| -11% | -$232K | 0.01% | 725 |
|
|
2023
Q3 | $2.32M | Sell |
6,474
-1,196
| -16% | -$429K | 0.01% | 672 |
|
|
2023
Q2 | $2.91M | Buy |
7,670
+255
| +3% | +$96.7K | 0.01% | 638 |
|
|
2023
Q1 | $3.55M | Buy |
7,415
+621
| +9% | +$297K | 0.02% | 562 |
|
|
2022
Q4 | $2.86M | Buy |
6,794
+1,243
| +22% | +$523K | 0.02% | 601 |
|
|
2022
Q3 | $2.32M | Buy |
5,551
+590
| +12% | +$246K | 0.01% | 643 |
|
|
2022
Q2 | $2.46M | Buy |
4,961
+5
| +0.1% | +$2.48K | 0.02% | 652 |
|
|
2022
Q1 | $2.79M | Buy |
4,956
+372
| +8% | +$210K | 0.02% | 656 |
|
|
2021
Q4 | $3.46M | Buy |
4,584
+112
| +3% | +$84.6K | 0.02% | 609 |
|
|
2021
Q3 | $3.34M | Buy |
4,472
+381
| +9% | +$284K | 0.02% | 581 |
|
|
2021
Q2 | $2.64M | Buy |
4,091
+41
| +1% | +$26.4K | 0.02% | 659 |
|
|
2021
Q1 | $2.31M | Buy |
4,050
+48
| +1% | +$27.4K | 0.01% | 675 |
|
|
2020
Q4 | $2.33M | Buy |
4,002
+64
| +2% | +$37.3K | 0.02% | 652 |
|
|
2020
Q3 | $2.03M | Buy |
3,938
+6
| +0.2% | +$3.09K | 0.02% | 613 |
|
|
2020
Q2 | $1.78M | Buy |
3,932
+12
| +0.3% | +$5.42K | 0.02% | 624 |
|
|
2020
Q1 | $1.37M | Buy |
3,920
+360
| +10% | +$126K | 0.01% | 623 |
|
|
2019
Q4 | $1.32M | Buy |
+3,560
| New | +$1.32M | 0.01% | 737 |
|
|
2017
Q1 | – | Sell |
-130
| Closed | -$24K | – | 1009 |
|
|
2016
Q4 | $24K | Buy |
+130
| New | +$24K | ﹤0.01% | 1295 |
|